Published in BMJ on January 22, 2000
Mimicking microbial 'education' of the immune system: a strategy to revert the epidemic trend of atopy and allergic asthma? Respir Res (2000) 0.78
Paying for the NHS. Democratic control should not be dismissed. BMJ (2000) 0.75
Paying for the NHS. Spending should be decided by public and politicians. BMJ (2000) 0.75
Requirement for IL-13 independently of IL-4 in experimental asthma. Science (1998) 10.76
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest (1999) 8.38
The inverse association between tuberculin responses and atopic disorder. Science (1997) 7.46
CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med (1997) 4.06
Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med (1999) 3.36
Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest (1997) 2.68
Role of microbial burden in aetiology of allergy and asthma. Lancet (1999) 1.92
Tick histamine-binding proteins: isolation, cloning, and three-dimensional structure. Mol Cell (1999) 1.88
Bacterial CpG DNA activates immune cells to signal infectious danger. Adv Immunol (1999) 1.75
Reversing the trend: reducing the prevalence of asthma. J Allergy Clin Immunol (1999) 1.50
Mechanisms of deficient interferon-gamma production in atopic diseases. Clin Exp Allergy (1999) 1.48
Allergy treatment with a peptide vaccine. Lancet (1990) 1.45
Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae. Immunology (1998) 1.44
Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol (1997) 1.29
Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiency. Eur J Biochem (1994) 1.20
Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol (1998) 1.17
Injection of anti-IgE antibodies will suppress IgE and allergic symptoms. Allergy (1999) 0.87
Epitope-specific antibody response to IgE by mimotope immunization. J Immunol (1998) 0.87
Human T helper cell differentiation is regulated by the combined action of cytokines and accessory cell-dependent costimulatory signals. J Immunol (1997) 0.87
Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy (1998) 0.85
Inhibition of interleukin-5 with a monoclonal antibody attenuates allergic inflammation. Allergy (1997) 0.85
Prevention of the development of immediate hypersensitivity and airway hyperresponsiveness following in vivo treatment with soluble IL-4 receptor. Int Arch Allergy Immunol (1996) 0.85
Chemokines and IL-5: major players of eosinophil recruitment in asthma. Clin Exp Allergy (1999) 0.82